GCN2 and perk kinase inhibitors and methods of use thereof | Patent Publication Number 20220274934
US 20220274934 A1Publication DateSep 1, 2022
Original AssigneeDeciphera Pharmaceuticals Llc
Current AssigneeDeciphera Pharmaceuticals Llc
Inventor/ApplicantsYu Mi Ahn
Kristen Stoltz
Gada Al-Ani
Jeffery Zwicker
Patrick Kearney
Gada AI-Ani
Bertrand LeBourdonnec
Daniel L. Flynn
Salim Javed
Bertrand Le Bourdonnec
Kristen Stoltz
Gada Al-Ani
Jeffery Zwicker
Patrick Kearney
Gada AI-Ani
Bertrand LeBourdonnec
Daniel L. Flynn
Salim Javed
Bertrand Le Bourdonnec
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.